[Skip to Content]

Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom – (Eye Journal AOP)

24 July 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login